Top story · September 27, 2026
A decade-long struggle with substance abuse highlights ongoing challenges.
Cindy's son faced a ten-year battle with addiction, underscoring the persistent challenges of substance abuse.
Read the storySeptember 26, 2026
Overview of Universal Ibogaine Inc.'s market presence and operations.
September 24, 2026
Psyence Biomedical's $5M investment aims to advance ibogaine program in the U.S.
September 24, 2026
Collaboration focuses on LSD, ketamine, and ibogaine combinations.
September 24, 2026
Peaking offers a raw look at psychedelics' impact on mental health.
September 23, 2026
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
September 23, 2026
The company aims to advance ibogaine research for mental health.
September 23, 2026
Psyence BioMed's new investment aims to advance ibogaine research.
September 23, 2026
Company invests $5 million in PsyLabs for ibogaine research and production.
September 23, 2026
New patents cover LSD, ketamine, ibogaine combinations for mental health.
September 23, 2026
Patent applications cover novel combinations of LSD, ketamine, and ibogaine.
September 23, 2026
Collaboration with Clearmind Medicine enhances therapeutic potential for mental health and substance use disorders.
September 23, 2026
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
September 23, 2026
No link established between ibogaine and Gerber's death, but heart risks persist.
September 23, 2026
New patent applications aim to enhance mental health treatments using LSD, ketamine, ibogaine.
September 23, 2026
Ibogaine's potential for treating addiction draws attention as regulations evolve.
September 23, 2026
New patent applications cover LSD, ketamine, and ibogaine combinations for mental health.
September 23, 2026
Ibogaine is explored for its potential in treating addiction and mental health.
September 23, 2026
Ibogaine is studied for treating opioid addiction and PTSD.
September 23, 2026
Presley Gerber's death raises concerns over alternative therapies in rehab.
September 23, 2026
Psyence and PsyLabs collaborate to advance ibogaine for opioid use disorder.
September 22, 2026
Model Presley Gerber sought ibogaine therapy in Mexico amid addiction struggles.
September 22, 2026
TMZ reports on circumstances surrounding Presley Gerber's death.
September 22, 2026
Presley Gerber explored ibogaine for addiction treatment months before his passing.
September 22, 2026
Presley Gerber's journey with mental health and substance use highlights ongoing challenges.
September 22, 2026
New extended treatment integrates ibogaine therapy with cultural exploration.
September 22, 2026
Model's overdose at Malibu rehab prompts scrutiny of ibogaine use.
September 22, 2026
Cindy Crawford's son advocated for ibogaine before his passing.
September 22, 2026
Brigham and Women's Hospital receives $2.3 million to assess ibogaine's safety for opioid use disorder.
September 22, 2026
Gerber's death investigated as suspected overdose amid mental health struggles.
September 22, 2026
Ibogaine, a psychoactive alkaloid, is explored for addiction treatment.
September 22, 2026
Presley Gerber's use of ibogaine highlights its controversial role in addiction treatment.
September 22, 2026
Cindy Crawford's son, Presley Gerber, shared valuable insights before his untimely death.
September 21, 2026
Cindy Crawford's son passes at 27, sister reveals his challenges.
September 21, 2026
Details emerge about the reported death of Cindy Crawford's son.
September 21, 2026
Presley Gerber's death highlights ongoing struggles with addiction and mental health.
September 21, 2026
Bryan Hubbard emphasizes ibogaine's role in addiction treatment, not as a miracle solution.
September 21, 2026
Psychedelic compound ibogaine draws interest amid regulatory shifts.
September 21, 2026
Cindy Crawford's son shared his ibogaine experience months before passing in rehab.
September 21, 2026
Psychedelic use for spiritual purposes is rising as traditional religious participation declines.
September 21, 2026
Model and advocate for mental health, Presley Gerber, passed away in a rehab facility.
September 21, 2026
Model Presley Gerber sought ibogaine treatment for addiction before passing at 27.
September 21, 2026
The model opens up about his recovery process on social media.
September 21, 2026
Model Cindy Crawford shared emotional words with her son Presley Gerber before his untimely death.
September 21, 2026
Gerber shared insights on recovery six months prior to his death.
September 21, 2026
Cindy Crawford and family expressed pride in Presley's recovery efforts.
September 21, 2026
Model Presley Gerber underwent ibogaine therapy in Cancun months before his passing.
September 21, 2026
Exploring lesser-known psychedelics and their potential therapeutic roles.
September 21, 2026
Model's passing at 27 raises questions about ibogaine's role in addiction recovery.
September 18, 2026
David Dardashti's ibogaine program celebrates milestone in addiction treatment innovation.
Newsletter
Occasional dispatches on research, policy, and treatment. No spam.